- Home
- SNBR vs ATOS Comparison
SNBR vs ATOS Comparison
Compare SNBR & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNBR
- ATOS
- Stock Information
- Founded
- SNBR 1987
- ATOS 2009
- Country
- SNBR United States
- ATOS United States
- Employees
- SNBR N/A
- ATOS N/A
- Industry
- SNBR Home Furnishings
- ATOS Biotechnology: Pharmaceutical Preparations
- Sector
- SNBR Consumer Discretionary
- ATOS Health Care
- Exchange
- SNBR Nasdaq
- ATOS Nasdaq
- Market Cap
- SNBR 150.1M
- ATOS 120.4M
- IPO Year
- SNBR 1998
- ATOS 2012
- Fundamental
- Price
- SNBR $5.11
- ATOS $0.86
- Analyst Decision
- SNBR Hold
- ATOS Strong Buy
- Analyst Count
- SNBR 2
- ATOS 3
- Target Price
- SNBR $9.00
- ATOS $6.25
- AVG Volume (30 Days)
- SNBR 558.3K
- ATOS 1.3M
- Earning Date
- SNBR 11-05-2025
- ATOS 11-12-2025
- Dividend Yield
- SNBR N/A
- ATOS N/A
- EPS Growth
- SNBR N/A
- ATOS N/A
- EPS
- SNBR N/A
- ATOS N/A
- Revenue
- SNBR $1,524,620,000.00
- ATOS N/A
- Revenue This Year
- SNBR N/A
- ATOS N/A
- Revenue Next Year
- SNBR $1.02
- ATOS N/A
- P/E Ratio
- SNBR N/A
- ATOS N/A
- Revenue Growth
- SNBR N/A
- ATOS N/A
- 52 Week Low
- SNBR $4.48
- ATOS $0.55
- 52 Week High
- SNBR $20.73
- ATOS $1.66
- Technical
- Relative Strength Index (RSI)
- SNBR 25.46
- ATOS 39.96
- Support Level
- SNBR $6.07
- ATOS $0.86
- Resistance Level
- SNBR $5.59
- ATOS $0.91
- Average True Range (ATR)
- SNBR 0.47
- ATOS 0.05
- MACD
- SNBR -0.04
- ATOS -0.02
- Stochastic Oscillator
- SNBR 7.02
- ATOS 4.01
About SNBR Sleep Number Corporation
Sleep Number Corp. is a wellness technology company engaged in the design, manufacturing, marketing and distribution of sleep solutions. The Company generates revenue by marketing and selling its smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). The products offered by the company are Mattresses, Bedding, Pillows and Furniture.
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.